OncoImmune
Dr. Chou obtained his PhD in Microbiology and Immunology from The Institute For Biomedical Sciences at The George Washington University. Dr. Chou is an experienced molecular immunologist trained under the supervision of Dr. Yang Liu and Dr. Pan Zheng with strong background in generation and characterization of cancer-specific monoclonal antibodies for immunotherapies.
This person is not in any teams
This person is not in any offices
OncoImmune
Based in Rockville, Maryland, OncoImmune is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biopharmaceuticals for the treatment of cancer and autoimmune disease.